IMPACT Therapeutics, Inc. – IPO Allotment Results, Shareholding Structure, and Key Investor Information
Key Points from the Announcement
- Final Offer Price Set at HK\$20.10 per H Share in the IPO on the Hong Kong Stock Exchange (Stock Code: 7630), with trading commencing on May 13, 2026.
- Global Offering Size: 41,977,000 H Shares offered, raising gross proceeds of HK\$843.7 million and net proceeds of HK\$759.5 million after estimated listing expenses.
- Over-allotment Option: 6,296,400 H Shares have been over-allocated and may be covered by exercising the over-allotment option or secondary market purchases.
- Public and Institutional Demand:
- Hong Kong Public Offering was oversubscribed by 2,282.4 times, with 221,788 valid applications and only 18,774 successful applicants for 4,197,800 shares (10% of the offer).
- International Offering was oversubscribed by 24.58 times for 37,779,200 shares (90% of the offer) placed to 137 investors.
- High Shareholder Concentration Alert: The top 25 placees received over 100% of the International Offering, and the top 25 H shareholders will hold over 87% of issued H Shares after listing. This concentration may lead to significant share price volatility even on small trading volumes.
- Lock-up Undertakings: Cornerstone investors and key pre-IPO shareholders are subject to lock-up periods ranging from six months (for cornerstone investors) to one year (for pre-IPO shareholders), restricting their ability to sell shares during this period.
- Public Float and Free Float Requirements Met: Upon listing, 57.06% of shares will be in public hands, with a “free float” (unrestricted) portion of 10.16%, satisfying regulatory requirements.
- Key Shareholders and Cornerstone Investors:
- Tencent, LAV USD entities, WWHCP, and several Chinese and international funds are significant holders, with details disclosed on specific allocations and waivers granted for their participation as cornerstone investors.
- Regulatory Waivers/Consents: Waivers obtained to allow existing shareholders and their associates to participate in the IPO as cornerstone investors and placees, with full compliance confirmed.
- Stabilization Measures: Goldman Sachs (Asia) L.L.C. may undertake price stabilization for 30 days post-listing but is not obligated to do so. No stabilization can occur after June 7, 2026.
- Termination Rights: The IPO underwriters can terminate the Hong Kong Public Offering under certain events up to 8:00 a.m. on the listing date, which could impact the offering and share price significantly if exercised.
Details Critical for Shareholders and Price-sensitive Information
- Potential Price Volatility:
- The high concentration of shareholding among a small group of investors means even small trades could move the share price substantially.
- Over-allocation & Stabilization:
- 6,296,400 shares have been over-allocated. If the over-allotment option is exercised or shares are purchased in the market, this could temporarily support the share price. If not, demand and price could fall after the stabilization period ends (June 7, 2026).
- Lock-up Expiry Dates:
- Cornerstone investors are locked up until November 12, 2026, and major pre-IPO shareholders until May 12, 2027. Large-scale sales after these dates could pressure the share price.
- Termination of Underwriting:
- If the underwriters terminate their obligations due to adverse events before listing, the IPO could be derailed, causing major price impact or delays.
- Connected Parties and Waivers:
- Allocation to cornerstone investors or placees who are existing shareholders, their associates, or connected clients has been approved by the exchange under strict conditions. Investors should note these allocations can impact future share supply and governance.
- Public and Free Float:
- The company will have more than 25% public float and at least 300 shareholders, meeting listing requirements, but the actual free float is just over 10% of issued shares, potentially limiting liquidity.
- Trading Information:
- Shares will trade in board lots of 200 H Shares each, under stock code 7630, starting May 13, 2026.
Comprehensive Allotment and Shareholding Structure Details
- Total Shares upon Listing: 276,165,130
- Top Placee Concentration:
- Top 1 placee: 1.73% of total issued shares
- Top 5 placees: 12.74%
- Top 10 placees: 29.50%
- Top 25 placees: 36.75%
- H Shareholder Concentration:
- Top 1 H Shareholder: 13.95% of H Shares
- Top 5: 47.90%
- Top 10: 64.60%
- Top 25: 89.13%
- Major Pre-IPO Shareholders (subject to 12-month lock-up):
- Decheng IMPACT Limited: 8.53%
- Tencent (Guangxi Tencent Venture Investment): 5.65%
- LAV Enterprise, LAV Innovation, LAV Integra, LAV Impetus: collectively over 13% (with additional shares from the IPO)
- Several other funds and individuals hold between 0.5% and 5% each
- Cornerstone Investors (subject to 6-month lock-up):
- BPV and Huatai Capital: 1.73%
- Huang River (Tencent associate): 1.13%
- Prosper High (Tencent associate): 0.28%
- LAV Star/Opportunities: 0.35% each
- Several international funds (e.g., WWHCP, GSC Fund, Vision Fund, Horizon Fund, First Quarter Moon) hold between 0.07% and 0.36% each
Other Noteworthy Details
- Regulatory Compliance: All necessary waivers, consents, and approvals have been obtained for allocations to connected parties and cornerstone investors. All allocations are at arm’s length and on equivalent terms to other investors.
- Connected Client Placements:
- Small allocations (under 0.02% each) were made to CICC Financial Trading (hedged via OTC swaps) and China AMC, both acting on behalf of underlying clients, all of whom are independent third parties and not collective investment schemes unauthorized by the SFC.
- Stabilization Manager: Goldman Sachs (Asia) L.L.C. will act as stabilization manager and may intervene in the market for up to 30 days post-listing, but is not obligated to do so.
Investor Guidance
Investors should be aware of the following risks and potential price-moving factors:
- High concentration of shareholding (top 25 shareholders holding nearly 90% of H Shares) can amplify price swings and reduce liquidity.
- Any sale of shares by cornerstone or pre-IPO shareholders after lock-up expiry (after November 2026 or May 2027) may exert downward pressure on the share price.
- Possible price pressure after the end of the stabilization period (June 7, 2026) if the over-allotment option is not exercised.
- Any exercise of underwriter termination rights before listing constitutes a major execution risk.
Investors are encouraged to read the full prospectus and all official announcements before making investment decisions.
Disclaimer
This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. Potential investors should consult the official prospectus and seek professional advice before making any investment decisions. The information is based on the official allotment results and public filings as of May 12, 2026, and may be subject to further updates and changes.
